Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic

The number of cases of the coronavirus-induced disease-2019 (COVID-19) continues to increase exponentially worldwide. In this crisis situation, the management of ST-segment elevation myocardial infarction (STEMI) is challenging. In this review, we outline the risks and benefits of primary PCI vs. th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yerasi, Charan, Case, Brian C., Forrestal, Brian J., Chezar-Azerrad, Chava, Hashim, Hayder, Ben-Dor, Itsik, Satler, Lowell F., Mintz, Gary S., Waksman, Ron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241397/
https://www.ncbi.nlm.nih.gov/pubmed/32471712
http://dx.doi.org/10.1016/j.carrev.2020.05.027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241397/
https://www.ncbi.nlm.nih.gov/pubmed/32471712
http://dx.doi.org/10.1016/j.carrev.2020.05.027

Ejemplares similares